What is the current valuation of the China Epilepsy Surgery Market?

The market valuation was 74.4 USD Million in 2024. Read More

What is the projected market size for the China Epilepsy Surgery Market by 2035?

The projected valuation for 2035 is 132.0 USD Million. Read More

What is the expected CAGR for the China Epilepsy Surgery Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 5.35%. Read More

Which surgical procedure types dominate the China Epilepsy Surgery Market?

Resective Surgery and Functional Surgery are key segments, with valuations of 30.0 to 55.0 USD Million and 20.0 to 35.0 USD Million, respectively. Read More

How does the market perform in terms of patient age groups?

The Adult segment leads with a valuation range of 40.0 to 70.0 USD Million, followed by Geriatric at 16.4 to 29.0 USD Million. Read More

What are the leading technologies utilized in the China Epilepsy Surgery Market?

Imaging Techniques and Neurostimulation Devices are prominent, with valuations of 29.4 to 52.0 USD Million and 20.0 to 35.0 USD Million, respectively. Read More

Which healthcare settings are most involved in epilepsy surgeries in China?

Hospitals and Specialized Epilepsy Centers are significant, with valuations of 30.0 to 55.0 USD Million and 20.0 to 40.0 USD Million. Read More

Who are the key players in the China Epilepsy Surgery Market?

Key players include Medtronic, Johnson & Johnson, Stryker, and Boston Scientific, among others. Read More

What types of epilepsy are primarily treated through surgery in China?

Focal Epilepsy and Refractory Epilepsy are major indications, with valuations of 30.0 to 55.0 USD Million and 20.0 to 40.0 USD Million, respectively. Read More

What trends are anticipated in the China Epilepsy Surgery Market over the next decade?

The market is likely to experience growth driven by advancements in technology and increasing awareness, particularly from 2025 to 2035. Read More

China Epilepsy Surgery Market

China Epilepsy Surgery Market Research Report By Procedure Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT)) and By End User (Hospitals & Clinics, Specialty Centers) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.35%

2024 Market Size

$ 74.4 Million

2035 Market Size

$ 132 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/51356-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Surgical Procedure Type (USD Million)
  1. 4.1.1 Resective Surgery
  2. 4.1.2 Functional Surgery
  3. 4.1.3 Lesionectomy
  4. 4.1.4 Hemispherectomy
2. 4.2 Healthcare, BY Indication (USD Million)
  1. 4.2.1 Focal Epilepsy
  2. 4.2.2 Generalized Epilepsy
  3. 4.2.3 Refractory Epilepsy
  4. 4.2.4 Non-epileptic Seizures
3. 4.3 Healthcare, BY Patient Age Group (USD Million)
  1. 4.3.1 Pediatric
  2. 4.3.2 Adolescent
  3. 4.3.3 Adult
  4. 4.3.4 Geriatric
4. 4.4 Healthcare, BY Technology (USD Million)
  1. 4.4.1 Neurostimulation Devices
  2. 4.4.2 Surgical Navigation Systems
  3. 4.4.3 Robotic Surgery Systems
  4. 4.4.4 Imaging Techniques
5. 4.5 Healthcare, BY Healthcare Setting (USD Million)
  1. 4.5.1 Hospitals
  2. 4.5.2 Specialized Epilepsy Centers
  3. 4.5.3 Outpatient Clinics
  4. 4.5.4 Research Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (CN)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Johnson & Johnson (CN)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Stryker (CN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boston Scientific (CN)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Abbott Laboratories (CN)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 NeuroPace (CN)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 LivaNova (CN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Natus Medical (CN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Integra LifeSciences (CN)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE
3. 6.3 CHINA MARKET ANALYSIS BY INDICATION
4. 6.4 CHINA MARKET ANALYSIS BY PATIENT AGE GROUP
5. 6.5 CHINA MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 CHINA MARKET ANALYSIS BY HEALTHCARE SETTING
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY PATIENT AGE GROUP, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY PATIENT AGE GROUP, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY HEALTHCARE SETTING, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY HEALTHCARE SETTING, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SURGICAL PROCEDURE TYPE, 2026-2035 (USD Million)
  2. 7.2.2 BY INDICATION, 2026-2035 (USD Million)
  3. 7.2.3 BY PATIENT AGE GROUP, 2026-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million)
  5. 7.2.5 BY HEALTHCARE SETTING, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China Epilepsy Surgery Market Segmentation

China Epilepsy Surgery Market By Surgical Procedure Type (USD Million, 2026-2035)

Resective Surgery
Functional Surgery
Lesionectomy
Hemispherectomy

China Epilepsy Surgery Market By Indication (USD Million, 2026-2035)

Focal Epilepsy
Generalized Epilepsy
Refractory Epilepsy
Non-epileptic Seizures

China Epilepsy Surgery Market By Patient Age Group (USD Million, 2026-2035)

Pediatric
Adolescent
Adult
Geriatric

China Epilepsy Surgery Market By China Epilepsy Surgery Market (USD Million, 2026-2035)

Neurostimulation Devices
Surgical Navigation Systems
Robotic Surgery Systems
Imaging Techniques

China Epilepsy Surgery Market By China Epilepsy Surgery Market Setting (USD Million, 2026-2035)

Hospitals
Specialized Epilepsy Centers
Outpatient Clinics
Research Institutions

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”